Atossa Therapeutics
ATOS
#10745
Rank
NZ$39.38 M
Marketcap
NZ$3.95
Share price
1.35%
Change (1 day)
179.03%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$6.79

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.95. In 2025 the company made an earnings per share (EPS) of NZ-$7.09 a decrease over its 2024 EPS that were of NZ-$5.33.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.79-4.23%
2025NZ-$7.0932.89%
2024NZ-$5.33-15.56%
2023NZ-$6.3114.29%
2022NZ-$5.5216.67%
2021NZ-$4.74-90.86%
2020NZ-$51.83-2.96%
2019NZ-$53.41-63.09%
2018NZ-$144.70-49.63%
2017NZ-$287.29-57.87%
2016NZ-$681.92-74.01%
2015NZ-$2,623-9.18%
2014NZ-$2,889-12.86%
2013NZ-$3,31570.73%
2012NZ-$1,94234.07%
2011NZ-$1,448263.41%
2010NZ-$398.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.32-320.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$16.08-331.57%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.92-386.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.35-80.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.37-94.70%๐Ÿ‡บ๐Ÿ‡ธ USA